About this trial
Surgical correction of pelvic organ prolapse (POP) may be associated with the development of postoperative stress urinary incontinence (SUI). This clearly affects women's satisfaction and their quality of life, and may require subsequent medical and/or surgical treatments.
On the other hand, pre-existing SUI could resolve after corrective prolapse surgery. Similarly, urge urinary incontinence (UUI) could appear or improve after vaginal POP surgery. Therefore, it is of paramount importance to know the prevalence of urinary incontinence after POP vaginal surgery and incontinence resolution in our population. Identifying the risk factors for the development of urinary incontinence may allow to provide individualized treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women who will undergo vaginal surgery for pelvic organ prolapse
Disqualifiers
inhability to give consent to the study
Trial population
Women referred to different Spanish hospitals for symptomatic pelvic organ prolapse who are candidates for surgical correction of their POP.
Trial design
Cohort
Prospective
Treatments tested in this trial
Vaginal surgery for pelvic organ prolapse
Procedure/SurgeryVaginal surgery of any vaginal compartment for pelvic organ prolapse
Treatment groups
Trial outcomes
Primary outcomes
Stress urinary incontinence (SUI).
Urgency urinary incontinence (UUI)
Secondary outcomes
Incontinence severity
Patient's satisfaction with the procedure.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Hospital Universitari Vall d'Hebron Research Institute
Lead sponsor
University Hospital Virgen de la Arrixaca, Murcia
Collaborator
Hospital Materno-Infantil de Canarias. Las Palmas de Gran Canaria. Spain
Collaborator
Hospital de l'Esperit Sant
Collaborator
Consorci Sanitari de Terrassa
Collaborator
This trial is not recruiting at the moment. You can still explore other options: